Stay informed with the latest litigation news. Explore now

IP Verse

Crush-Resistant Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion - EP3115041B1

EP3115041

ETHYPHARM
Application Number
EP16183449A
Filing Date
Mar 1, 2007
Status
Granted And Under Opposition
Sep 22, 2023
Grant Date
Oct 25, 2023
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3115041B1 was granted to Ethypharm on Oct 25, 2023 following the initial filing on Mar 1, 2007 under the application number EP16183449A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

G L PHARMAJul 25, 2024ADMISSIBLE
HERTIN UND PARTNER RECHTS UND PATENTANWALTE PARTG MBBJul 25, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents